YEAR: 2012
Psychiatry Educational Meeting:"Psychiatry in Practice: Advancing Patient Care with Current and Novel Treatment" sponsored by Janssen MEWA - Day 2
27-28 January 2012, Beirut
Psychiatry Educational Meeting:"Psychiatry in Practice: Advancing Patient Care with Current and Novel Treatment" sponsored by Janssen MEWA - Day1
27-28 January 2012, Beirut
On demand webcast based on the "Psychiatry in Practice: Advancing Patient Care with Current and Novel Treatment"
27-28 January 2012, Beirut
On demand webcast based on the 10th Nordic Psychiatric Academy Schizophrenia
20-21 January 2012, Shanghai
International Expert Meeting on Alcohol Dependence
24 February 2012, Copenhagen
Janssen European Pain Forum 2012"Optimising Pain Management in the 21st Century"
23-25 February 2012, Paris
Evidence-based Medicine Bipolar Disorder
20-24 February 2012, Copenhagen
Evidence-based Medicine in Dementia & Old Age Depression
6-11 February 2012, Copenhagen
Evidence-based Medicine in Bipolar Disorder
26-30 March 2012, Copenhagen
4th Scientific Symposium on Niemann-Pick Type C: The Expanding Universe of NP-C
23-25 March 2012, Athens
"Time to revisit the definition and treatment of bipolar I disorder in a multidimensional way" satellite symposium at the ISBD
16 March 2012, Istanbul
"Reduction of alcohol consumption - a new treatment paradigm in alcohol dependence" satellite symposium at the European Congress of Psychiatry with educational financial support provided by Lundbeck
5 March 2012, Prague
"Evidence and expectations in the treatment of bipolar depression and major depressive disorder" satellite symposium at the European Congress of Psychiatry with educational financial support provided by AstraZeneca
5 March 2012, Prague
"Finding a way out of depression: a challenge in common clinical practice", satellite symposium at the European Congress of Psychiatry with educational financial support provided by Eli Lilly operations GesmbH
4 March 2012, Prague
Expert Meeting:"Asenapine: multifunctional antipsychotic for the treatment of bipolar I disorder"
2 March 2012, Prague
MDD Regional Informational Conference "Optimizing Care and Treatment Outcomes for Patients with Major Depressive Disorder"
26-27 April 2012, Vienna
Evidence-based Medicine in Schizophrenia
23-27 April 2012, Copenhagen
ISAD - 6th Biennal Conference
18-20 April 2012, London
ISAD 6th Biennal Conference
18-20 April 2012, London
Standalone "New perspectives in alcohol dependence and bipolar disorder"
14-15 April 2012, Dublin
Go for Zero: A Realistic Target for Patients with Epilepsy? standalone symposium with educational financial support provided by UCB
25-26 May 2012, Madrid
Evidence-based Medicine in Anxiety Disorders
21-25 May 2012, Copenhagen
Evidence-based Medicine in Dementia & Old Age Depression
25-29 June 2012, Copenhagen
Standalone "Understanding the science of schizophrenia: making the most of current treatment options for our patients" sponsored by Janssen Pharmaceutica NV
15-16 June 2012, Berlin
Webcast based on the Stand alone symposium:" Understanding the science of schizophrenia: making the most of current treatment options for our patients", sponsored by Janssen Pharmaceutica NV, Berlin, 15-16 June 2012
15-16 June 2012, Berlin
Live broadcast based on the stand alone symposium "Understanding the science of schizophrenia: making the most of current treatment options for our patients", sponsored by Janssen Pharmaceutica NV
15-16 June 2012, Berlin
Evidence-based Medicine in Mood Disorders
11-15 June 2012, Copenhagen
"Successful management of depressive symptoms: a patient-centred approach", satellite symposium at the 28th CINP Congress with educational financial support provided by AstraZeneca
6 June 2012, Stockholm
"Asenapine - a multifunctional antipsychotic. Beyond symptom control in bipolar disorder" a satellite symposium at the CINP with educational financial support provided by H. Lundbeck A/S
4 June 2012, Stockholm
Scientific Expert Forum: "From Monotherapy to Rational Polypharmacy: Improving Clinical Decision Making in Patients with Diabetic Peripheral Neuropathic Pain"
1 June 2012, Madrid
Webcast based on the Psychiatry Educational Meeting:"Psychiatry in Practice: Advancing Patient Care with Current and Novel Treatment" sponsored by Janssen MEWA
24 July 2012, Beirut
Summer Course on Fear and Anxiety
8-13 July 2012, Florence
Working with ANXIETY from symptom to self. 10th of conference of the World Association for Person Centered and Experiential Psychotherapy and Counseling
8-12 July 2012, Antwerp
Satellite symposium at the WONCA 2012 "The patient who drinks too much - identifying alcohol problems in primary care" - Educational financial support provided by H. Lundbeck A/S
6 July 2012, Vienna
Evidence-based Medicine in Bipolar Disorder
24-28 September 2012, Copenhagen
Workshop "New technologies in interventional pain management techniques" International Meeting
21-22 September 2012, Ghent
Clinical Expert Forum for Schizophrenia:" Schizophrenia: from Science to Clinical Practice"
20-21 September 2012, Bucharest
Evidence-based Medicine in Mood Disorders
3-7 September 2012, Copenhagen
Evidence-based Medicine in Anxiety Disorder
29 October-2 November 2012, Copenhagen
International Parkinson's Disease Masterclass "The changing faces of Parkinson's Disease"
26-27 October 2012, Berlin
"Emotional deregulation within depression" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Servier
16 October 2012, Vienna
"The past, present and future treatment of patients with schizophrenia how far have we come?" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Janssen Pharmaceutica
16 October 2012, Vienna
E-learning based on the "The past, present and future treatment of patients with schizophrenia - how far have we come?" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Janssen Pharmaceutica
16 October 2012 ,
"The changing landscape in the long term treatment of schizophrenia" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Eli Lilly and Company
15 October 2012, Vienna
"A new chapter in the history of depression" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Servier
15 October 2012, Vienna
"Optimising management of alcohol dependence - rational for expanding the treatment continuum" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
15 October 2012, Vienna
"Future directions in the management of mood disorders" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by AstraZeneca
15 October 2012, Vienna
Regional Informational Conference: " Improving Outcomes in Diabetic Peripheral Neuropathic Pain: Latest Developments and Future Strategies"
15-16 November 2012, Vienna
"The dark side of the brain: exploring negative symptoms and new therapeutic prospects for patients with schizophrenia" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by F. Hoffmann-La Roche Ltd
14 October 2012, Vienna
"Aiming for remission in depression guided by patient profile" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Eli Lilly and Company
14 October 2012, Vienna
"Bipolar I disorder, improving clinical and functional outcomes" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
14 October 2012, Vienna
25th ECNP Congress
13-17 October 2012, Vienna
"Outstanding needs in depression and how multimodal antidepressants may solve them" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
13 October 2012, Vienna
"Windows of opportunity in age-related cognitive disorders" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Dr. Willmar Schwabe Pharmaceuticals
13 October 2012, Vienna
"Transforming the long-term management of schizophrenia" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Otsuka Pharmaceutical Commercialization and development Inc. and H. Lundbeck A/S
13 October 2012, Vienna
"Overcoming the challenge of inadequate response in major depressive disorder" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by AstraZeneca
13 October 2012, Vienna
"Beyond symptom control in schizophrenia" - Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
13 October 2012, Vienna
"ADHD: Emerging Evidence and Clinical Implications" Satellite symposium
4-5 October 2012, Brussels
The dark side of the brain: exploring negative symptoms and new therapeutic prospects for patients with schizophrenia a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by F. Hoffmann-La Roche Ltd
14-Oct-12, Vienna
Outstanding needs in depression and how multimodal antidepressants may solve them a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
13-Oct-12, Vienna
Windows of opportunity in age-related cognitive disorders a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Dr. Willmar Schwabe Pharmaceuticals
13-Oct-12, Vienna
Transforming the long-term management of schizophrenia a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Otsuka Pharmaceutical Commercialization and development Inc. and H. Lundbeck A/S
13-Oct-12, Vienna
Overcoming the challenge of inadequate response in major depressive disorder a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by AstraZeneca
13-Oct-12, Vienna
Beyond symptom control in schizophrenia a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
13-Oct-12, Vienna
Aiming for remission in depression guided by patient profile a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Eli Lilly and Company
14-Oct-12, Vienna
The changing landscape in the long term treatment of schizophrenia a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided byEli Lilly and Company
15-Oct-12, Vienna
Emotional deregulation within depression a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Servier
16-Oct-12, Vienna
A new chapter in the history of depression a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Servier
15-Oct-12, Vienna
Optimising management of alcohol dependence - rational for expanding the treatment continuum a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
15-Oct-12, Vienna
Bipolar I disorder, improving clinical and functional outcomes a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by H. Lundbeck A/S
14-Oct-12, Vienna
Future directions in the management of mood disorders a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by AstraZeneca
15-Oct-12, Vienna
The past, present and future treatment of patients with schizophrenia how far have we come? a Satellite symposium on the occasion of the 25th ECNP Congress with educational financial support provided by Janssen Pharmaceutica N.V.
16-Oct-12, Vienna
25th ECNP Congress, 13-17 October 2012, Vienna, Austria
13-17 October, Vienna
International Expert Meeting on Alcohol Dependence
16 November 2012, Amsterdam
Standalone "Activities Delivering Hope, Empowerment and Success: bringing ADHES to life for you and your patients" with educational financial support provided by Janssen Pharmaceutica N.V.
16-17 November 2012, Vienna
E-learning based on the standalone "Activities delivering hope, empowerment and success: bringing ADHES to life for you and your patients" with educational financial support provided by Janssen Pharmaceutica N.V.
16-17 November 2012, Vienna
Depression Clinical Expert Forum:"Understanding depression and anxiety disorders in patients with comorbidities"
15-16 November 2012, Rome
Evidence-based Medicine in Bipolar Disorder
13-16 November 2012, Copenhagen
Med forum 3rd Course "Update in Psychopharmacotherapeutics"
7-10 November 2012, Marrakech